Codexis Inc. logo

Codexis Inc. (CDXS)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
2. 24
+0.08
+3.7037%
$
220.88M Market Cap
- P/E Ratio
- Div Yield
404,500 Volume
-1.18 Eps
$ 2.16
Previous Close
Add Transaction
Day Range
2.11 2.26
Year Range
0.96 3.87
Want to track CDXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript

Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript

Codexis, Inc. (CDXS) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.25 per share a year ago.

Zacks | 2 months ago
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Codexis (CDXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform

Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform

Codexis, Inc. delivered strong FY25 results, with revenue up 19% to $70.4M, driven by a $37.8M technology transfer agreement with Merck. CDXS's ECO Synthesis platform targets the expanding siRNA/RNA therapeutics market, offering scalable, high-margin enzymatic manufacturing as a disruptive alternative to chemical synthesis. Operational improvements included gross margin expansion to 64%, narrowed net loss, and SG&A expense reductions, positioning CDXS for financial sustainability.

Seekingalpha | 4 months ago
Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript

Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript

Codexis, Inc. (CDXS) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago
Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

Codexis (CDXS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.13 per share a year ago.

Zacks | 4 months ago
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)

Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)

Codexis (CDXS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks | 8 months ago
Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript

Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript

Codexis, Inc. ( CDXS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Georgia Erbez - CFO & Chief Business Officer Stephen Dilly Alison Moore - President, CEO & Director Britton Jimenez Conference Call Participants Kristen Kluska - Cantor Fitzgerald & Co., Research Division Tollef Kohrman - Craig-Hallum Capital Group LLC, Research Division Chad Wiatrowski - TD Cowen, Research Division Presentation Operator Greetings, and welcome to the Codexis Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this conference is being recorded.

Seekingalpha | 8 months ago
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates

Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.29 per share a year ago.

Zacks | 8 months ago
Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript

Codexis, Inc. (CDXS) Q2 2025 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Georgia L. Erbez - Chief Financial Officer Kevin Norrett - Chief Operating Officer Stephen George Dilly - President, CEO & Chairman Conference Call Participants Allison Marie Bratzel - Piper Sandler & Co., Research Division Brendan Mychal Smith - TD Cowen, Research Division Kristen Brianne Kluska - Cantor Fitzgerald & Co., Research Division Matthew Gregory Hewitt - Craig-Hallum Capital Group LLC, Research Division Matthew Jay Stanton - Jefferies LLC, Research Division Operator Welcome to Codexis Second Quarter 2025 Earnings Conference Call.

Seekingalpha | 11 months ago
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates

Codexis (CDXS) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.32 per share a year ago.

Zacks | 11 months ago
Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript

Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript

Codexis, Inc. (NASDAQ:CDXS ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Carrie McKim - Director of Investor Relations Stephen Dilly - President and Chief Executive Officer Georgia Erbez - Chief Financial Officer Stefan Lutz - Senior Vice President of Research Conference Call Participants Kristen Kluska - Cantor Fitzgerald Tycho Peterson - Jefferies Allison Bratzel - Piper Sandler Dan Arias - Stifel Matthew Hewitt - Craig-Hallum Brendan Smith - TD Cowen Operator Greetings and welcome to the Codexis First Quarter 2025 Earnings Conference Call and webcast. At this time, all participants are in a listen-only mode.

Seekingalpha | 1 year ago
Loading...
Load More